Management of epilepsy in the elderly

Epilepsia
L J Willmore

Abstract

Epilepsy in elderly patients is a growing worldwide challenge; as the population ages, the prevalence of epilepsy increases. Management of epilepsy in elderly patients requires an understanding of their unique medical and pharmacologic characteristics. Accurate assessment of seizures, thorough neurologic assessment to define etiology, and evaluation of concomitant illnesses and living situations are necessary for comprehensive treatment planning and informed management. Expect elderly patients to present challenges to treatment that include concomitant diseases, obligatory polypharmacy with accompanying drug interactions, and age-related changes in renal and hepatic physiology that alter drug metabolism and elimination. Elderly patients have declining intellectual function, motor impairment, or altered special sensory function that make them susceptible to dose-related CNS side effects of antiepileptic drugs (AEDs). When AEDs are added to the medical regimen of an elderly patient, the physician must review all prescribed drugs. Drugs prescribed for concomitant illnesses such as behavioral problems, cardiovascular disease, hypertension, and infection may alter the distribution and metabolism of AEDs, with an impact on efficacy a...Continue Reading

References

Jul 1, 1979·Clinical Pharmacology and Therapeutics·D J GreenblattR I Shader
Feb 1, 1979·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·J BruniB J Wilder
Jul 15, 1978·British Medical Journal·B Beermann, O Edhag
Jun 3, 1978·British Medical Journal·W P StephensP H Baylis
Aug 1, 1977·Age and Ageing·D C Lambie, F I Caird
Oct 1, 1977·British Journal of Clinical Pharmacology·M J EadieJ H Tyrer
Oct 11, 1975·Journal of Pharmaceutical Sciences·A D BenderG Reichard
Feb 1, 1975·British Journal of Clinical Pharmacology·M J HayesA H Short
Nov 1, 1992·Epilepsy Research·L M OjemannJ Wallace
Dec 1, 1990·Neurology·G B YoungD W Zochodne
Aug 1, 1990·Archives of Neurology·M F RomanelliL A Coben
Nov 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·C Y Sung, N S Chu
Oct 1, 1989·Journal of Clinical Pharmacology·D J GreenblattJ S Harmatz
Oct 1, 1989·British Journal of Clinical Pharmacology·R J RileyB K Park
Feb 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H A WynneO F James
Oct 1, 1989·Clinical Pharmacokinetics·S Dawling, P Crome
Aug 1, 1989·Neurology·E FaughtP C Miller
Aug 31, 1985·Lancet·P N PatsalosC M Wiles
Jan 1, 1987·Epilepsia·J M Pellock
Jun 1, 1988·Journal of Clinical Pharmacology·B J Cusack
Jan 1, 1988·Epilepsia·W A HauserJ C Brust
Nov 1, 1988·Epilepsia·D W RobertsonJ D Leander
Jun 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·P CrawfordD Chadwick
Jan 1, 1987·Clinical Pharmacokinetics·S M Wallace, R K Verbeeck
Dec 1, 1986·British Journal of Clinical Pharmacology·N HockingsD L Davidson
Jul 1, 1986·Epilepsia·K LühdorfA M Plesner
Jun 1, 1986·Postgraduate Medical Journal·K A HewetsonR D Watson
Jun 1, 1985·Clinical Pharmacology and Therapeutics·L A BauerR H Levy
Jun 1, 1985·Clinical Pharmacology and Therapeutics·M B Lahr
Nov 1, 1985·Epilepsia·A J WilenskyR H Levy
Jul 29, 1971·The New England Journal of Medicine·M M ReidenbergF Sjöqvist
Oct 1, 1967·American Heart Journal·S LouisF McDowell

❮ Previous
Next ❯

Citations

Dec 6, 2001·Current Treatment Options in Neurology·Mercedes P. Jacobson
Jun 25, 1999·Progress in Neurobiology·P GareriG De Sarro
Oct 6, 2001·Drugs & Aging·L GiorgiM Risner
Oct 26, 1999·Epilepsia·M J McLean
Feb 24, 2001·Mayo Clinic Proceedings·J I Sirven
Mar 24, 2009·Epilepsy & Behavior : E&B·Ludger Tebartz van ElstMike Kerr
Jan 30, 2004·British Journal of Clinical Pharmacology·P A RoutledgeK W Woodhouse
Oct 20, 1998·Journal of the American Geriatrics Society·J I Sirven
Aug 22, 2003·Irish Journal of Medical Science·S TimmonsC Twomey
Aug 16, 2005·Acta Neurologica Scandinavica·J GroseljUNKNOWN TOP-INT-51 Investigators' Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.